. /.  WORLD TRADE  
ORGANIZATION  G/SPS/N/USA/843/Add.1 
23 February 2005 
 
 (05-0767) 
Committee on Sanitary a nd Phytosanitary Measures Original:   English 
  
 
NOTIFICATION  
 
Addendum
 
  
 The following communication, dated 21 February 2005, is being circulated at the request of 
the Delegation of the United States
. 
 
_______________ 
  
Final Rule; Secondary Direct Food Additives Permi tted in Food for Human Consumption; Chlorine 
dioxide manufactured by electrolysis of an aqueous  solution of sodium chlorite [Docket No. 2003F–
0535]  
  The U.S. Food and Drug Administration (FDA) pub lished a Final Rule in the Federal Register 
on 14 February 2005 (70 FR 7394) amending the food additive regulations  in §173.300 (21 CFR 
173.300) to permit the manufacture of chlorine dioxi de by electrolysis of an aqueous solution of 
sodium chlorite.  The additive may be used as an antimicrobial agent in water used in the processing 
of poultry, fruits and vegetables.  The complete text of the Final Rule in the Federal Register, 70 FR 
7394 (available in English), can be found on the Internet at: 
http://www.access.gpo.gov/su_docs/fedreg/a050214c.html
. or 
http://a257.g.akamaitech.net/7/257/2422/01j an20051800/edocket.access.gpo.gov/2005/05-2808.htm  
  This rule is effective 14 February 2005.   This action is in response to a petition from Vulcan Chemicals filed by FDA on 1 December 
2003;  the complete text of the Filing Notice in th e Federal Register, 68 FR 67195 (in English), can be 
found on the Internet at:  http://www.access.gpo.gov/su_docs/fedreg/a031201c.html
. 
  Any person who will be adversely affected by this regulation may file written or electronic 
objections and requests for a hearing with the Division of Dockets Management by 16 March 2005.  
You may submit written objections and requests for a hearing, identified by Docket No. 2003F–0535, 
by any of the following methods: 
•  Federal eRulemaking Portal:  http://www.regulations.gov
.  Follow the instructions for submitting 
comments. 
•  Agency Web site:  http://www.fda.gov/dockets/ecomments .  Follow the instructions for submitting 
comments on the agency Web site. 
•  E-mail:  fdadockets@oc.fda.gov .  Include Docket No. 2003F–0535 in the subject line of your e-mail 
message. 
•  Fax:  301–827–6870. 
•  Mail/Hand delivery/Courier [For paper, disk, or CD-ROM submissions]:  Division of Dockets 
Management (HFA-305), Food and Drug Administra tion, 5630 Fishers Lane, rm. 1061, Rockville, 
MD 20852. G/SPS/N/USA/843/Add.1 
Page 2  
 
 All submissions received must include the agency name and docket number for this rulemaking.  All objections received wi ll be posted without change to  
http://www.fda.gov/ohrms/dockets/default.htm
, including any personal information provided.  For 
detailed instructions on submitting objections, see th e "Objection and Hearing Requests" section of 
the Final Rule. 
 
 For access to the docket to read background documents or comments received, go to http://www.fda.gov/ohrms/dockets/default.htm
 and insert the docket number, found in brackets in the 
heading of this document, into the "Search" box an d follow the prompts and/or go to the Division of 
Dockets Management, 5630 Fishers La ne, Room 1061, Rockville, MD 20852. 
 
 For further information contact:  Paul C. DeLeo, Center for Food Safety and Applied 
Nutrition (HFS–265), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740–3835, 301-436-1302.  
__________